179 related articles for article (PubMed ID: 30730433)
1. Effect of Topical Periocular Steroid Use on Intraocular Pressure: A Retrospective Analysis.
Maeng MM; De Moraes CG; Winn BJ; Glass LRD
Ophthalmic Plast Reconstr Surg; 2019; 35(5):465-468. PubMed ID: 30730433
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
Sheppard JD; Comstock TL; Cavet ME
Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
[TBL] [Abstract][Full Text] [Related]
3. Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.
Rajpal RK; Digby D; D'Aversa G; Mah F; Hollander DA; Conway T
J Ocul Pharmacol Ther; 2011 Jun; 27(3):305-8. PubMed ID: 21574815
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological validation of a feline model of steroid-induced ocular hypertension.
Bhattacherjee P; Paterson CA; Spellman JM; Graff G; Yanni JM
Arch Ophthalmol; 1999 Mar; 117(3):361-4. PubMed ID: 10088814
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
Holland EJ; Djalilian AR; Sanderson JP
Cornea; 2009 Dec; 28(10):1139-43. PubMed ID: 19770719
[TBL] [Abstract][Full Text] [Related]
6. Ocular-hypertensive response to topical steroids in children.
Kwok AK; Lam DS; Ng JS; Fan DS; Chew SJ; Tso MO
Ophthalmology; 1997 Dec; 104(12):2112-6. PubMed ID: 9400772
[TBL] [Abstract][Full Text] [Related]
7. Intraocular pressure response to loteprednol etabonate in known steroid responders.
Bartlett JD; Horwitz B; Laibovitz R; Howes JF
J Ocul Pharmacol; 1993; 9(2):157-65. PubMed ID: 8345288
[TBL] [Abstract][Full Text] [Related]
8. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers.
Holland EJ; Bartlett JD; Paterno MR; Usner DW; Comstock TL
Cornea; 2008 Jan; 27(1):50-5. PubMed ID: 18245967
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Loteprednol 0.5% and Fluorometholone 0.1% After Strabismus Surgery in Children.
Yoo YJ; Yang HK; Hwang JM
J Ocul Pharmacol Ther; 2018; 34(6):468-476. PubMed ID: 29958057
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Ocular Steroid Hypertensive Response in Children.
Kaur S; Dhiman I; Kaushik S; Raj S; Pandav SS
J Glaucoma; 2016 Apr; 25(4):343-7. PubMed ID: 25651206
[TBL] [Abstract][Full Text] [Related]
11. Ocular hypertensive response to topical dexamethasone ointment in children.
Lee YJ; Park CY; Woo KI
Korean J Ophthalmol; 2006 Sep; 20(3):166-70. PubMed ID: 17004631
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
Breusegem C; Vandewalle E; Van Calster J; Stalmans I; Zeyen T
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):573-6. PubMed ID: 18824737
[TBL] [Abstract][Full Text] [Related]
13. Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation.
Raj A; Salvador-Culla B; Anwar H; Sykakis E; Figueiredo MS; Figueiredo FC
Cornea; 2020 Jan; 39(1):45-51. PubMed ID: 31517723
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the concentration of copper and iron in the aqueous humour and intraocular pressure in rabbits treated with topical steroids.
Iqbal Z; Muhammad Z; Shah MT; Bashir S; Khan T; Khan MD
Clin Exp Ophthalmol; 2002 Feb; 30(1):28-35. PubMed ID: 11885791
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%.
Akingbehin AO
Br J Ophthalmol; 1983 Oct; 67(10):661-3. PubMed ID: 6615752
[TBL] [Abstract][Full Text] [Related]
16. Discontinuing nasal steroids might lower intraocular pressure in glaucoma.
Bui CM; Chen H; Shyr Y; Joos KM
J Allergy Clin Immunol; 2005 Nov; 116(5):1042-7. PubMed ID: 16275373
[TBL] [Abstract][Full Text] [Related]
17. A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.
Qin Y; Lam S; Yam GH; Choy KW; Liu DT; Chiu TY; Li WY; Lam DS; Pang CP; Fan DS
Acta Ophthalmol; 2012 Sep; 90(6):559-63. PubMed ID: 21044276
[TBL] [Abstract][Full Text] [Related]
18. Steroid-induced ocular hypertension with loteprednol etabonate 0.2%--a case report.
Lu E; Fujimoto LT; Vejabul PA; Jew RL
Optometry; 2011 Jul; 82(7):413-20. PubMed ID: 21543264
[TBL] [Abstract][Full Text] [Related]
19. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.
Ng JS; Fan DS; Young AL; Yip NK; Tam K; Kwok AK; Lam DS
Ophthalmology; 2000 Nov; 107(11):2097-100. PubMed ID: 11054340
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
